Osteoboost Health, Inc.

When it comes to bone health, proven solutions make all the difference. The New York Times highlighted the lack of strong evidence for vibration plates marketed for weight loss and muscle building. These platforms vary widely, with no standard design for medical treatment. Osteoboost was built with a clear purpose. Our technology delivers targeted mechanical stimulation at the optimal frequency and magnitude proven to activate bone cells and slow the loss of bone density. Backed by a randomized, sham-controlled clinical trial and FDA clearance, Osteoboost is designed specifically for bone health. Unlike general vibration platforms, it focuses on the hips and spine, the areas most at risk for fractures. https://lnkd.in/gkWTDbpy?

NASA astronauts Suni Williams and Butch Wilmore are back on Earth after months in space, but their recovery is just beginning. Extended time in zero gravity leads to muscle loss, circulation issues, and a significant drop in bone density. Astronauts lose about 1% of their bone density per month in space despite rigorous exercise routines. NASA has long studied ways to counteract this, inspiring the technology behind Osteoboost’s precision vibration therapy. Our FDA-cleared wearable helps people at risk for bone loss maintain their bone health wherever they are. Whether in space or on the ground, protecting bone health is key to staying strong and mobile for life. Read more: https://lnkd.in/ghHPK9cr?

Stronger bones mean a stronger future. At #LSISummit2025, health tech leaders are coming together to explore the next wave of innovation in longevity, wearable tech, and non-invasive treatments. Our CEO, Laura Yecies, will be there to join the conversation. Osteopenia remains one of the most overlooked issues in women’s health. Osteoboost is changing that with the first FDA-cleared, non-drug treatment for low bone density—helping people stay active, independent, and resilient as they age. If you’re attending, let’s connect and discuss the future of bone health. ??https://lnkd.in/dw_teTUK #LSIUSA #MedTech LSI

Doug Lucas, a leading voice in bone health and longevity, recently reviewed Osteoboost—breaking down how our wearable belt delivers targeted vibration therapy to help slow bone loss and support stronger bones. In his review, he covers:? ?? How Osteoboost’s technology works and its role in bone health ?? The science behind precision vibration therapy ?? The clinical study data behind its effectiveness Dr. Doug is all about evidence-based solutions, and we’re glad to see him highlight Osteoboost as a promising option for proactive bone health. Watch his full review here: https://lnkd.in/g5au5VF2??

Ahead of #InternationalWomensDay, we’re celebrating the strength, independence, and achievements of women everywhere. ????At Osteoboost, we’re committed to empowering women to stay strong, independent, and active as they age. More women will suffer an osteoporotic fracture than experience a heart attack, stroke, and breast cancer—combined. That’s why we provide an FDA-cleared, non-drug treatment for low bone density, helping women protect their bone health for the long term. We honor all the women breaking barriers in health, science, and beyond, especially those taking charge of their well-being. Here’s to strong women, in every aspect of life. #StrongerWithWomen #Longevity #WomenInHealth #BoneHealth #WearableTech

Osteopenia can affect women at any age, even those who seem to do everything right. Gwyneth Paltrow shared that she was diagnosed with osteopenia at 37, showing that bone density loss can begin and become serious much earlier than most people expect. A recent article by Isabelle Paquette in Woman’s World explores how lifestyle, genetics, and nutrition all play a role in maintaining bone health over time. At Osteoboost, we are committed to raising awareness and providing proactive solutions for bone health. More conversations like this can help people take action sooner. Read the full article here: https://lnkd.in/gnE-JfTc??

Millions are at risk of bone loss, yet effective non-drug solutions have been scarce—until now. Osteoboost has been awarded its 6th U.S. patent for our FDA-cleared wearable device, designed to help strengthen bones with NASA-inspired vibration therapy. What makes our device unique: ? Clinically proven in a gold-standard randomized controlled trial to slow bone loss with targeted vibration therapy ? Smart sensors ensure each session delivers an optimized, personalized therapeutic dose ? The first and only FDA-cleared non-drug treatment for low bone density This patent strengthens our commitment to providing effective, non-invasive options for people at risk of osteoporosis. Read more here: https://lnkd.in/ghsRt6-C

Women with low bone density need and deserve innovation. Big pharma has essentially thrown in the towel - I'm proud that Bone Health Technologies | Osteoboost is focusing on and making progress in this important area of unmet need. Frailty and fractures need not be inevitable. #medtech #innovation #womenshealth #osteoporosis https://lnkd.in/ghsRt6-C

Great several days at #ViveEvent in Nashville - conversations on #womenshealth #ai and, of course, #osteoporosis with inspiring clinicians, digital health leaders, investors, and health systems. Thanks,?AgeTech Collaborative? from AARP,?for including us in your booth.

We're headed to the ViVE this Sunday, with one of the first Osteoboost devices to roll off the production line. If you'll be there, stop by for a demo! Booth 1502-8 (in the AARP pavilion). #ViVEvent??#MeetMeAtViVE?#ViVE2025